Super Session 3 – Metabolic Diseases

Digitalization for the benefit of the diabetes' patient

Super Session 3 – Metabolic Diseases

08:45 - 10:15 Plenary Room A
Digitalization is becoming an increasingly important part of healthcare, life sciences and clinical trials. Stakeholders from these areas are contributing to this development in different ways. The session will present various perspectives of how diabetes patients can benefit from such digital revolution.

Hosted by:

Medeon

Medeon

Lund University

Lund University

Sponsored by:

MSD

MSD

Moderator(s): Dr. Gaspar Taroncher-Oldenburg - Editor-at-Large, Nature Publishing Group

Speaker(s):
Dr. Michel de Baar - Executive Director, BD&L - Infectious Diseases, Vaccines, Cardiometabolic, Immunology & Inflammation, MSD Mr. Thomas Magnusson - Chairman of the Board, The Diabetes Organisation of Sweden Dr. Damon Tojjar - Managing Director, Easy Diabetes

full program